Regencell Bioscience Holdings (Regencell Bioscience Holdings) Short-Term Debt : $0.00 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Regencell Bioscience Holdings Short-Term Debt?

Regencell Bioscience Holdings's Short-Term Debt for the quarter that ended in Jun. 2023 was $0.00 Mil.

Regencell Bioscience Holdings's annual Short-Term Debt declined from Jun. 2021 ($3.68 Mil) to Jun. 2022 ($0.00 Mil) but then stayed the same from Jun. 2022 ($0.00 Mil) to Jun. 2023 ($0.00 Mil).

Regencell Bioscience Holdings Short-Term Debt Historical Data

The historical data trend for Regencell Bioscience Holdings's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Short-Term Debt Chart

Regencell Bioscience Holdings Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Short-Term Debt

2.08

3.07

3.68

Regencell Bioscience Holdings Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Short-Term Debt	Get a 7-Day Free Trial				3.68	-	-	-	-

Regencell Bioscience Holdings Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Regencell Bioscience Holdings Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG

Website

https://www.regencellbioscience.com

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.